{
    "xml": "<topic id=\"PHP2561\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/ondansetron\" basename=\"ondansetron\" title=\"ONDANSETRON\">\n<title>ONDANSETRON</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1045\" namespace=\"/interactions/list-of-drug-interactions/5ht3-receptor-antagonists/ondansetron\">Ondansetron</xref>\n</p>\n<data name=\"vtmid\">108418007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_495132402\" title=\"5HT&#1079; receptor antagonists\">5HT&#1079; receptor antagonists</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP36576\" outputclass=\"drugAction\" rev=\"1.9\" parent=\"/drugs/ondansetron\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Ondansetron is a specific 5HT<sub>3</sub>-receptor antagonist which blocks 5HT<sub>3</sub> receptors in the gastro-intestinal tract and in the CNS.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36556\" outputclass=\"indicationsAndDose\" rev=\"1.90\" parent=\"/drugs/ondansetron\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Moderately emetogenic chemotherapy or radiotherapy</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 8&#8239;mg, dose to be taken 1&#8211;2 hours before treatment, alternatively (by rectum) initially 16&#8239;mg, dose to be administered 1&#8211;2 hours before treatment, alternatively (by intramuscular injection or by slow intravenous injection) initially 8&#8239;mg, dose to be administered immediately before treatment, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 8&#8239;mg, dose to be taken 1&#8211;2 hours before treatment, alternatively (by rectum) initially 16&#8239;mg, dose to be administered 1&#8211;2 hours before treatment, alternatively (by intramuscular injection or by intravenous infusion) initially 8&#8239;mg, dose to be administered immediately before treatment, intravenous infusion to be given over at least 15 minutes, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severely emetogenic chemotherapy (consult product literature for dose of concomitant corticosteroid)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>24&#8239;mg, dose to be taken 1&#8211;2 hours before treatment, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">Initially by rectum</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>16&#8239;mg, dose to be administered 1&#8211;2 hours before treatment, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">Initially by intramuscular injection or by slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;65 years</p>\n<p>Initially 8&#8239;mg, dose to be administered immediately before treatment, followed by (by intramuscular injection or by slow intravenous injection) 8&#8239;mg every 4&#8239;hours if required for 2 doses, alternatively (by continuous intravenous infusion) 1&#8239;mg/hour for up to 24 hours, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">Initially by intramuscular injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 66&#8211;74 years</p>\n<p>Initially 8&#8239;mg, to be given immediately before treatment, intravenous infusion to be administered over at least 15 minutes, followed by (by intramuscular injection or by intravenous infusion) 8&#8239;mg every 4&#8239;hours if required for 2 doses, alternatively (by continuous intravenous infusion) 1&#8239;mg/hour for up to 24 hours, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult 18&#8211;65 years</p>\n<p>Initially 16&#8239;mg, to be given immediately before treatment over at least 15 minutes, followed by (by intramuscular injection or by slow intravenous injection) 8&#8239;mg every 4&#8239;hours if required for 2 doses, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 66&#8211;74 years</p>\n<p>Initially 16&#8239;mg, to be given immediately before treatment over at least 15 minutes, followed by (by intramuscular injection or by intravenous infusion) 8&#8239;mg every 4&#8239;hours if required for 2 doses, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult 75 years and over</p>\n<p>Initially 8&#8239;mg, to be given immediately before treatment over at least 15 minutes, followed by (by intravenous infusion) 8&#8239;mg every 4&#8239;hours if required for 2 doses, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of postoperative nausea and vomiting</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>16&#8239;mg, dose to be taken 1 hour before anaesthesia, alternatively (by intramuscular injection or by slow intravenous injection) 4&#8239;mg, dose to be administered at induction of anaesthesia.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of postoperative nausea and vomiting</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>4&#8239;mg for 1 dose.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36583\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/ondansetron\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Congenital long QT syndrome</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36587\" outputclass=\"cautions\" rev=\"1.11\" parent=\"/drugs/ondansetron\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Adenotonsillar surgery</ph>; <ph outputclass=\"caution\">subacute intestinal obstruction</ph>; <ph outputclass=\"caution\">susceptibility to QT-interval prolongation (including electrolyte disturbances)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36553\" outputclass=\"interactions\" rev=\"1.17\" parent=\"/drugs/ondansetron\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (5HT<sub>3</sub>-receptor Antagonists).</p>\n<p>Caution with concomitant use of drugs that prolong QT interval.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36537\" outputclass=\"sideEffects\" rev=\"1.12\" parent=\"/drugs/ondansetron\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Constipation</ph>; <ph outputclass=\"sideEffect\">flushing</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">injection site-reactions</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arrhythmias</ph>; <ph outputclass=\"sideEffect\">bradycardia</ph>; <ph outputclass=\"sideEffect\">chest pain</ph>; <ph outputclass=\"sideEffect\">hiccups</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">movement disorders</ph>; <ph outputclass=\"sideEffect\">seizures</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">transient visual disturbances</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"sideEffect\">transient blindness</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With rectal use</p>\n<p>\n<ph outputclass=\"sideEffect\">rectal irritation</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36550\" outputclass=\"pregnancy\" parent=\"/drugs/ondansetron\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available; avoid unless potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36590\" outputclass=\"breastFeeding\" parent=\"/drugs/ondansetron\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk in <i>animal</i> studies&#8212;avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36571\" outputclass=\"hepaticImpairment\" parent=\"/drugs/ondansetron\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Maximum 8&#8239;mg daily in moderate or severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36599\" outputclass=\"directionsForAdministration\" rev=\"1.14\" parent=\"/drugs/ondansetron\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>For <i>intravenous infusion</i> (<i>Zofran</i>\n<tm tmtype=\"reg\"/>), give continuously or intermittently in Glucose 5% or Glucose 5% with Potassium chloride 0.3% or Sodium chloride 0.9% or Sodium chloride 0.9% with Potassium chloride 0.3% or Mannitol 10% or Ringers solution; for intermittent infusion, dilute the required dose in 50&#8211;100&#8239;mL of infusion fluid and give over at least 15 minutes.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\n<p>Orodispersible films and lyophylisates should be placed on the tongue, allowed to disperse and swallowed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57463\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/ondansetron\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of oral liquid formulations may include strawberry.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP36547\" outputclass=\"patientAndCarerAdvice\" rev=\"1.21\" parent=\"/drugs/ondansetron\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer orodispersible films and lyophilisates.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP2561-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ondansetron\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension, oral solution</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77541\" title=\"Tablet\" namespace=\"/drugs/ondansetron/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77561\" title=\"Orodispersible tablet\" namespace=\"/drugs/ondansetron/orodispersible-tablet\">Orodispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77565\" title=\"Orodispersible film\" namespace=\"/drugs/ondansetron/orodispersible-film\">Orodispersible film</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77553\" title=\"Oral solution\" namespace=\"/drugs/ondansetron/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77547\" title=\"Oral lyophilisate\" namespace=\"/drugs/ondansetron/oral-lyophilisate\">Oral lyophilisate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77550\" title=\"Solution for injection\" namespace=\"/drugs/ondansetron/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77543\" title=\"Suppository\" namespace=\"/drugs/ondansetron/suppository\">Suppository</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78221\" namespace=\"/treatment-summaries/nausea-and-labyrinth-disorders\" title=\"Nausea and labyrinth disorders\" count=\"1\" rel=\"backlink\">Nausea and labyrinth disorders</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"1\" rel=\"backlink\">Emergency treatment of poisoning</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1045\" namespace=\"/interactions/list-of-drug-interactions/5ht3-receptor-antagonists/ondansetron\" title=\"Ondansetron\" count=\"1\" rel=\"link\">Ondansetron</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77541\" namespace=\"/drugs/ondansetron/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77561\" namespace=\"/drugs/ondansetron/orodispersible-tablet\" title=\"Orodispersible tablet\" count=\"1\" rel=\"link\">Orodispersible tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77565\" namespace=\"/drugs/ondansetron/orodispersible-film\" title=\"Orodispersible film\" count=\"1\" rel=\"link\">Orodispersible film</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77553\" namespace=\"/drugs/ondansetron/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77547\" namespace=\"/drugs/ondansetron/oral-lyophilisate\" title=\"Oral lyophilisate\" count=\"1\" rel=\"link\">Oral lyophilisate</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77550\" namespace=\"/drugs/ondansetron/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77543\" namespace=\"/drugs/ondansetron/suppository\" title=\"Suppository\" count=\"1\" rel=\"link\">Suppository</xref>\n</links>\n</topic>",
    "id": "PHP2561",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/ondansetron",
    "basename": "ondansetron",
    "title": "ONDANSETRON",
    "interactants": [
        {
            "id": "bnf_int_1045",
            "label": "Ondansetron"
        }
    ],
    "vtmid": "108418007",
    "drugClassification": [
        "5HT&#1079; receptor antagonists"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Ondansetron is a specific 5HT3-receptor antagonist which blocks 5HT3 receptors in the gastro-intestinal tract and in the CNS.",
                "html": "<p>Ondansetron is a specific 5HT<sub>3</sub>-receptor antagonist which blocks 5HT<sub>3</sub> receptors in the gastro-intestinal tract and in the CNS.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Moderately emetogenic chemotherapy or radiotherapy",
                        "html": "Moderately emetogenic chemotherapy or radiotherapy"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially mouth"
                    ],
                    "textContent": "Initially by mouth",
                    "html": "Initially by mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 8 mg, dose to be taken 1&#8211;2 hours before treatment, alternatively (by rectum) initially 16 mg, dose to be administered 1&#8211;2 hours before treatment, alternatively (by intramuscular injection or by slow intravenous injection) initially 8 mg, dose to be administered immediately before treatment, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 8&#8239;mg, dose to be taken 1&#8211;2 hours before treatment, alternatively (by rectum) initially 16&#8239;mg, dose to be administered 1&#8211;2 hours before treatment, alternatively (by intramuscular injection or by slow intravenous injection) initially 8&#8239;mg, dose to be administered immediately before treatment, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>"
                    },
                    {
                        "textContent": "Initially 8 mg, dose to be taken 1&#8211;2 hours before treatment, alternatively (by rectum) initially 16 mg, dose to be administered 1&#8211;2 hours before treatment, alternatively (by intramuscular injection or by intravenous infusion) initially 8 mg, dose to be administered immediately before treatment, intravenous infusion to be given over at least 15 minutes, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 8&#8239;mg, dose to be taken 1&#8211;2 hours before treatment, alternatively (by rectum) initially 16&#8239;mg, dose to be administered 1&#8211;2 hours before treatment, alternatively (by intramuscular injection or by intravenous infusion) initially 8&#8239;mg, dose to be administered immediately before treatment, intravenous infusion to be given over at least 15 minutes, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severely emetogenic chemotherapy (consult product literature for dose of concomitant corticosteroid)",
                        "html": "Severely emetogenic chemotherapy (consult product literature for dose of concomitant corticosteroid)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous infusion"
                    ],
                    "textContent": "Initially by intravenous infusion",
                    "html": "Initially by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "24 mg, dose to be taken 1&#8211;2 hours before treatment, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>24&#8239;mg, dose to be taken 1&#8211;2 hours before treatment, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>"
                    },
                    {
                        "textContent": "16 mg, dose to be administered 1&#8211;2 hours before treatment, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>16&#8239;mg, dose to be administered 1&#8211;2 hours before treatment, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>"
                    },
                    {
                        "textContent": "Initially 8 mg, dose to be administered immediately before treatment, followed by (by intramuscular injection or by slow intravenous injection) 8 mg every 4 hours if required for 2 doses, alternatively (by continuous intravenous infusion) 1 mg/hour for up to 24 hours, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 8&#8239;mg, dose to be administered immediately before treatment, followed by (by intramuscular injection or by slow intravenous injection) 8&#8239;mg every 4&#8239;hours if required for 2 doses, alternatively (by continuous intravenous infusion) 1&#8239;mg/hour for up to 24 hours, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>",
                        "ageGroup": "18&#8211;65 years"
                    },
                    {
                        "textContent": "Initially 8 mg, to be given immediately before treatment, intravenous infusion to be administered over at least 15 minutes, followed by (by intramuscular injection or by intravenous infusion) 8 mg every 4 hours if required for 2 doses, alternatively (by continuous intravenous infusion) 1 mg/hour for up to 24 hours, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 8&#8239;mg, to be given immediately before treatment, intravenous infusion to be administered over at least 15 minutes, followed by (by intramuscular injection or by intravenous infusion) 8&#8239;mg every 4&#8239;hours if required for 2 doses, alternatively (by continuous intravenous infusion) 1&#8239;mg/hour for up to 24 hours, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>",
                        "ageGroup": "66&#8211;74 years"
                    },
                    {
                        "textContent": "Initially 16 mg, to be given immediately before treatment over at least 15 minutes, followed by (by intramuscular injection or by slow intravenous injection) 8 mg every 4 hours if required for 2 doses, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 16&#8239;mg, to be given immediately before treatment over at least 15 minutes, followed by (by intramuscular injection or by slow intravenous injection) 8&#8239;mg every 4&#8239;hours if required for 2 doses, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>",
                        "ageGroup": "18&#8211;65 years"
                    },
                    {
                        "textContent": "Initially 16 mg, to be given immediately before treatment over at least 15 minutes, followed by (by intramuscular injection or by intravenous infusion) 8 mg every 4 hours if required for 2 doses, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 16&#8239;mg, to be given immediately before treatment over at least 15 minutes, followed by (by intramuscular injection or by intravenous infusion) 8&#8239;mg every 4&#8239;hours if required for 2 doses, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>",
                        "ageGroup": "66&#8211;74 years"
                    },
                    {
                        "textContent": "Initially 8 mg, to be given immediately before treatment over at least 15 minutes, followed by (by intravenous infusion) 8 mg every 4 hours if required for 2 doses, then (by mouth) 8 mg every 12 hours for up to 5 days, alternatively (by rectum) 16 mg daily for up to 5 days.",
                        "html": "<p>Initially 8&#8239;mg, to be given immediately before treatment over at least 15 minutes, followed by (by intravenous infusion) 8&#8239;mg every 4&#8239;hours if required for 2 doses, then (by mouth) 8&#8239;mg every 12&#8239;hours for up to 5 days, alternatively (by rectum) 16&#8239;mg daily for up to 5 days.</p>",
                        "ageGroup": "75 years and over"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of postoperative nausea and vomiting",
                        "html": "Prevention of postoperative nausea and vomiting"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially mouth"
                    ],
                    "textContent": "Initially by mouth",
                    "html": "Initially by mouth"
                },
                "adult": [
                    {
                        "textContent": "16 mg, dose to be taken 1 hour before anaesthesia, alternatively (by intramuscular injection or by slow intravenous injection) 4 mg, dose to be administered at induction of anaesthesia.",
                        "html": "<p>16&#8239;mg, dose to be taken 1 hour before anaesthesia, alternatively (by intramuscular injection or by slow intravenous injection) 4&#8239;mg, dose to be administered at induction of anaesthesia.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of postoperative nausea and vomiting",
                        "html": "Treatment of postoperative nausea and vomiting"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or slow intravenous injection"
                    ],
                    "textContent": "By intramuscular injection or by slow intravenous injection",
                    "html": "By intramuscular injection or by slow intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "4 mg for 1 dose.",
                        "html": "<p>4&#8239;mg for 1 dose.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Congenital long QT syndrome",
                "html": "Congenital long QT syndrome"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Adenotonsillar surgery",
                "html": "Adenotonsillar surgery"
            },
            {
                "type": "cautions",
                "textContent": "subacute intestinal obstruction",
                "html": "subacute intestinal obstruction"
            },
            {
                "type": "cautions",
                "textContent": "susceptibility to QT-interval prolongation (including electrolyte disturbances)",
                "html": "susceptibility to QT-interval prolongation (including electrolyte disturbances)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (5HT3-receptor Antagonists).\n\nCaution with concomitant use of drugs that prolong QT interval.",
                "html": "<p>Appendix 1 (5HT<sub>3</sub>-receptor Antagonists).</p><p>Caution with concomitant use of drugs that prolong QT interval.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Constipation",
                        "html": "Constipation",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "flushing",
                        "html": "flushing",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "injection site-reactions",
                        "html": "injection site-reactions",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "bradycardia",
                        "html": "bradycardia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "chest pain",
                        "html": "chest pain",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hiccups",
                        "html": "hiccups",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "movement disorders",
                        "html": "movement disorders",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "seizures",
                        "html": "seizures",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "rare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "transient visual disturbances",
                        "html": "transient visual disturbances",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "transient blindness",
                        "html": "transient blindness",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "With intravenous use",
                            "html": "With intravenous use",
                            "routes": [
                                "intravenous"
                            ]
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "rectal irritation",
                        "html": "rectal irritation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With rectal use",
                            "html": "With rectal use",
                            "routes": [
                                "rectal"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available; avoid unless potential benefit outweighs risk.",
                "html": "<p>No information available; avoid unless potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk in animal studies&#8212;avoid.",
                "html": "<p>Present in milk in <i>animal</i> studies&#8212;avoid.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Maximum 8 mg daily in moderate or severe impairment.",
                "html": "<p>Maximum 8&#8239;mg daily in moderate or severe impairment.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Zofran ), give continuously or intermittently in Glucose 5% or Glucose 5% with Potassium chloride 0.3% or Sodium chloride 0.9% or Sodium chloride 0.9% with Potassium chloride 0.3% or Mannitol 10% or Ringers solution; for intermittent infusion, dilute the required dose in 50&#8211;100 mL of infusion fluid and give over at least 15 minutes.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Zofran</i>\n<tm tmtype=\"reg\"/>), give continuously or intermittently in Glucose 5% or Glucose 5% with Potassium chloride 0.3% or Sodium chloride 0.9% or Sodium chloride 0.9% with Potassium chloride 0.3% or Mannitol 10% or Ringers solution; for intermittent infusion, dilute the required dose in 50&#8211;100&#8239;mL of infusion fluid and give over at least 15 minutes.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Orodispersible films and lyophylisates should be placed on the tongue, allowed to disperse and swallowed.",
                "html": "<p>Orodispersible films and lyophylisates should be placed on the tongue, allowed to disperse and swallowed.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of oral liquid formulations may include strawberry.",
                "html": "<p>Flavours of oral liquid formulations may include strawberry.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer orodispersible films and lyophilisates.",
                "html": "<p>Patients or carers should be given advice on how to administer orodispersible films and lyophilisates.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension",
                "oral solution"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77541",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77561",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77565",
                "label": "Orodispersible film",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77553",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77547",
                "label": "Oral lyophilisate",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77550",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77543",
                "label": "Suppository",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78221",
                "label": "Nausea and labyrinth disorders",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1045",
                "label": "Ondansetron",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77541",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77561",
                "label": "Orodispersible tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77565",
                "label": "Orodispersible film",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77553",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77547",
                "label": "Oral lyophilisate",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77550",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77543",
                "label": "Suppository",
                "type": "medicinalForm"
            }
        ]
    }
}